Search results for " preclinical"

showing 10 items of 159 documents

Spin Hyperpolarization in Modern Magnetic Resonance.

2023

Magnetic resonance techniques are successfully utilized in a broad range of scientific disciplines and in a number of practical applications, with medical MRI being the most widely-known example. Currently, both fundamental and applied magnetic resonance are enjoying a major boost owing to the dramatic signal enhancement provided by the rapidly-developing field of spin hyperpolarization. Such techniques are able to enhance signal intensities in magnetic resonance by several orders of magnitude, and thus to largely overcome its major disadvantage of relatively low sensitivity compared to other analytical techniques. This provides new impetus for existing applications, and, even more importan…

Detectionscreening and diagnosisChemical SciencesGeneral ChemistryBiotechnology4.1 Discovery and preclinical testing of markers and technologies
researchProduct

Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity.

2014

A novel approach for the synthesis of unprecedented C3-mono-functionalized indolin-2-ones is reported, starting from 2-oxindole and chalcones. The reactions proceed regioselectively under mild conditions, without di- and tri-alkylated side products. The new compounds have been evaluated in vitro for their antiproliferative effects against the protozoan Leishmania infantum. Interestingly, they appear able to kill L. infantum promastigotes and amastigotes, without significant cytotoxic effects.

DiastereoselectivityLeishmanicidal activityIndolesStereochemistryClinical BiochemistryAntiprotozoal AgentsDrug Evaluation PreclinicalPharmaceutical Science2-oxindoleChemistry Techniques SyntheticBiochemistryCell LineMiceStructure-Activity RelationshipChalconeMichael additionparasitic diseasesDrug DiscoveryToxicity TestsAnimalsLeishmania infantumAmastigoteMolecular BiologyLeishmaniaOxindoles; Michael addition; Leishmania; Leishmanicidal activity; Diastereoselectivity; CyclizationbiologyDose-Response Relationship DrugChemistryOrganic Chemistrybiology.organism_classificationLeishmaniaCombinatorial chemistryIn vitroOxindolesCyclizationMichael reactionMolecular MedicineOxindoleLeishmania infantumBioorganicmedicinal chemistry
researchProduct

Chemical composition and antimicrobial activity of the essential oils of some species of Anthemis sect. Anthemis (Asteraceae) from Sicily

2017

The chemical composition of the essential oils isolated from the aerial parts of Anthemis arvensis L. subsp. arvensis, Anthemis cretica subsp. messanensis (Brullo) Giardina & Raimondo and from flowers and leaves of Anthemis cretica subsp. columnae (Ten.) Frezén were determinated by GC–FID and GC–MS analyses. Torreyol (85.4%) was recognised as the main constituent of the Anthemis arvensis subsp. arvensis essential oil, while in the essential oils of Anthemis cretica subsp. messanensis, collected on the rock and cultivated in Hortus Botanicus Panormitanus, (E)-chrysanthenyl acetate (28.8 and 24.2% resp.), 14-hydroxy-α-humulene (8.1 and 5.3% resp.), santolina triene (8 and 5.8% resp.) and …

Drug Evaluation PreclinicalRaimondoAnthemis arvensisFlowersMicrobial Sensitivity TestsPlant Science01 natural sciencesBiochemistryGas Chromatography-Mass Spectrometryessential oillaw.inventionAnalytical Chemistrychemistry.chemical_compoundBridged Bicyclo CompoundsAnti-Infective Agentsantibacterial activitylawSantolinaBotanyOils VolatileAnthemisSettore BIO/15 - Biologia FarmaceuticaChemical compositionSicilyAnthemis arvensis L. subsp. arvensiEssential oiltorreyolBicyclic MonoterpenesPolycyclic Sesquiterpenesalpha-PineneEucalyptolbiology010405 organic chemistryOrganic ChemistryAnthemis cretica subsp. columnae (Ten.) FrezénAsteraceaebiology.organism_classificationCyclohexanols0104 chemical sciencesPlant Leaves010404 medicinal & biomolecular chemistryEucalyptolchemistryMonoterpenesAnthemis cretica subsp. messanensis (Brullo) Giardina &ampAnthemisSesquiterpenes
researchProduct

New antitrichomonal drug-like chemicals selected by bond (edge)-based TOMOCOMD-CARDD descriptors.

2008

Bond-based quadratic indices, new TOMOCOMD-CARDD molecular descriptors, and linear discriminant analysis (LDA) were used to discover novel lead trichomonacidals. The obtained LDA-based quantitative structure-activity relationships (QSAR) models, using nonstochastic and stochastic indices, were able to classify correctly 87.91% (87.50%) and 89.01% (84.38%) of the chemicals in training (test) sets, respectively. They showed large Matthews correlation coefficients of 0.75 (0.71) and 0.78 (0.65) for the training (test) sets, correspondingly. Later, both models were applied to the virtual screening of 21 chemicals to find new lead antitrichomonal agents. Predictions agreed with experimental resu…

DrugAdultQuantitative structure–activity relationshipStereochemistrymedia_common.quotation_subjectOvariectomyDrug Evaluation PreclinicalTrichomonas InfectionsAntitrichomonal AgentsBiochemistryAnalytical Chemistrychemistry.chemical_compoundIn vivoMolecular descriptorDrug Resistance BacterialTrichomonas vaginalisAnimalsHumansRats Wistarmedia_commonChromatographyMolecular StructureChemistryDiscriminant AnalysisLinear discriminant analysisRatsAntitrichomonal agentEdge basedMolecular MedicineComputer-Aided DesignFemaleSoftwareBiotechnologyJournal of biomolecular screening
researchProduct

Preclinical evidence of new opioid modulators for the treatment of addiction.

2010

Addiction to opiates is one of the most severe forms of substance dependence, and despite a variety of pharmacological approaches to treat it, relapse is observed in a high percentage of subjects. New pharmacological compounds are necessary to improve the outcome of treatments and reduce adverse side effects. Moreover, drugs that act on the opioid system can also be of benefit in the treatment of alcohol or cocaine addiction. AREA COVERED BY THIS REVIEW: Recent preclinical studies of pharmacological agents for the treatment of opiate addiction (2008 to the present date).The reader will be informed of the latest drugs shown in animal models to modify dependence on opiates and the reinforcing…

DrugGABA Agentsmedia_common.quotation_subjectNarcotic AntagonistsDrug Evaluation PreclinicalReceptors Opioid muPharmacologyReceptors NicotinicBioinformaticsPharmacotherapyDopamineReceptors Opioid deltaCannabinoid Receptor ModulatorsmedicineAdrenergic alpha-2 Receptor AgonistsAnimalsPharmacology (medical)Adverse effectmedia_commonPharmacologySubstance dependencebusiness.industryAddictionReceptors Opioid kappaAntagonistGeneral Medicinemedicine.diseaseOpioid-Related DisordersRatsSubstance Withdrawal SyndromeOpioidReceptors OpioidDopamine AntagonistsFemalebusinessExcitatory Amino Acid Antagonistsmedicine.drugExpert opinion on investigational drugs
researchProduct

Covalent binding of drug metabolites to DNA ? a tool of predictive value?

1980

The presently available data suggest at least some correlation between covalent binding of drug metabolites to DNA and carcinogenicity of that drug. More data, however, are needed to establish the predictability of covalent DNA binding assays for extrahepatic cancer. A covalent binding assay requires administration of radioactively labelled compound to the experimental animals; the availability of labelled compound and requirements as to radiochemical purity, chemical and biochemical stability are limiting the applicability of this procedure. Many technical pitfalls accompany covalent DNA binding assays. It is concluded that at the present time DNA binding assays do not represent routine pr…

DrugHealth Toxicology and Mutagenesismedia_common.quotation_subjectLiver NeoplasmsDrug Evaluation PreclinicalCovalent bindingDNAGeneral MedicineIn Vitro TechniquesToxicologyPredictive valueMolecular biologyRatschemistry.chemical_compoundLiverchemistryBiochemistryCovalent bondCarcinogensAnimalsStandard testDNACarcinogenDrug metabolismmedia_commonArchives of Toxicology
researchProduct

Inkjet printing methodologies for drug screening

2010

We show for the first time a contactless, low-cost, and rapid drug screening methodology by employing inkjet printing for molecular dispensing in a microarray format. Picoliter drops containing a model substrate (D-glucose)/ inhibitor (D-glucal) couple were accurately dispensed on a single layer consisting of the enzymatic target (glucose oxidase) covalently linked to a functionalized silicon oxide support. A simple colorimetric detection method allowed one to prove the screening capability of the microarray with the possibility to assay with high reproducibility at the single spot level. Measurements of the optical signal as a function of concentration and of time verified the occurrence a…

DrugReproducibilitybiologyInkwellStereochemistryChemistrymedia_common.quotation_subjectDrug Evaluation PreclinicalNanotechnologySubstrate (printing)Microarray AnalysisSilicon DioxideAnalytical ChemistryGlucose OxidaseSensor arraybiology.proteinColorimetryInkGlucose oxidasedrug screening inkjet printing microarrays biological surfacesEnzyme InhibitorsColorimetryInkjet printingmedia_commonSettore CHIM/02 - Chimica Fisica
researchProduct

Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence.

2007

The ubiquitin-proteasome pathway is the main proteolytic system present in the nucleus and cytoplasm of all eukaryotic cells. Apoptosis activation induced by ubiquitin-proteasome pathway inhibition makes the proteasome a new target of anticancer therapy. Bortezomib is the first proteasome inhibitor to be approved by the US FDA; in 2003 as a third line and in 2005 as a second line therapy for the treatment of multiple myeloma only. This review focuses on the use of bortezomib, not only in its therapeutic role but also, more specifically, in its biologic role and discusses the most recent applications of the drug in solid tumors, both at a preclinical and clinical level.

Drugubiquitin-proteasome pathway proteasome inhibitorsSettore MED/06 - Oncologia Medicamedia_common.quotation_subjectClinical BiochemistryDrug Evaluation PreclinicalAntineoplastic AgentsApoptosisPharmacologyBortezomibNeoplasmsDrug DiscoverymedicineAnimalsHumansMultiple myelomamedia_commonPharmacologyClinical Trials as Topicbusiness.industryBortezomibmedicine.diseaseBoronic AcidsProteasomeClinical evidenceCytoplasmApoptosisPyrazinesProteasome inhibitorMolecular Medicinebusinessmedicine.drug
researchProduct

Cell Lines: A Tool for In Vitro Drug Metabolism Studies

2008

Primary cultured hepatocytes are a valuable in vitro model for drug metabolism studies. However, their widespread use is greatly hindered by the scarcity of suitable human liver samples. Moreover, the well-known in vitro phenotypic instability of hepatocytes, the irregular availability of fresh human liver for cell harvesting purposes, and the high batch-to-batch functional variability of hepatocyte preparations obtained from different human liver donors, seriously complicate their use in routine testing. To overcome these limitations, different cell line models have been proposed for drug metabolism screening. Human liver-derived cell lines would be ideal models for this purpose given thei…

Drug-Related Side Effects and Adverse ReactionsLiver cytologyTransgeneClinical BiochemistryCellCell Culture TechniquesDrug Evaluation PreclinicalBiologyCell LineXenobioticsCytochrome P-450 Enzyme SystemmedicineAnimalsCytochrome P-450 Enzyme InhibitorsHumansDrug InteractionsPharmacologyTransfectionmedicine.anatomical_structureLiverPharmaceutical PreparationsBiochemistryCell cultureHepatocyteStem cellGenetic EngineeringDrug metabolismCurrent Drug Metabolism
researchProduct

Acute myocardial effects of mitoxantrone in the rabbit

1987

Some clinical studies that were performed for the purpose of assessing the potential cardiotoxicity of mitoxantrone (DHAD) have shown that repeated administrations of the drugs in some patients cause a mild impairment of cardiac functions and morphological changes in the myocardial cells qualitatively similar to those elicited by anthracyclines. Since doxorubicin has been reported to cause acute cardiac effects, probably related to its chronic cardiotoxicity, experiments were carried out on the rabbit heart to investigate whether DHAD is also able to induce acute cardiac effects. Our results show that this drug caused a reversible dose-related impairment of cardiac contractility on the isol…

ElectrocardiographyDHADDrug Evaluation PreclinicalAnimalsHeartRabbitsIn Vitro TechniquesMitoxantroneantitumor drugsMyocardial ContractionCardiotoxicity
researchProduct